Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults

Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults

Botulinum toxin type A is approved for the focal treatment of spasticity; however, the effectiveness of abobotulinumtoxinA (aboBoNT-A) in patients with shoulder pain who have set reduced pain as a treatment goal is understudied. In addition, some patients encounter delays in accessing treatment prog...

Full description

Bibliographic Details
Main Authors: Marcelo Riberto, João Amaury Frances, Regina Chueire, Ana Cristina Ferreira Garcia Amorim, Denise Xerez, Tae Mo Chung, Lucia Helena Costa Mercuri, Sérgio Lianza, Eduardo Carvalho de Melo Rocha, Pascal Maisonobe, Thais Cuperman-Pohl, Patricia Khan
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Toxins
Subjects:
abobotulinumtoxinA
patients
post-stroke
shoulder pain
spasticity
therapeutic goal
Online Access:https://www.mdpi.com/2072-6651/14/11/809

Internet

https://www.mdpi.com/2072-6651/14/11/809

Similar Items